FGFR1 and endothelial dysfunction: Mechanistically, transforming growth factor-β (TGF-β) activated the FGFR1-ERK-YAP1 signaling cascade, which drove endothelial-to-mesenchymal transition (EndMT), inflammatory responses, and endothelial dysfunction.